Systemic comorbidities of rosacea: practice gaps among dermatologists.
Practice gap
Rosacea
Screening
Systemic comorbidities
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
24
04
2021
accepted:
03
09
2021
revised:
26
08
2021
pubmed:
13
9
2021
medline:
4
10
2022
entrez:
12
9
2021
Statut:
ppublish
Résumé
Rosacea is a chronic inflammatory skin condition that is associated with multiple systemic comorbidities, with the strongest evidence linking rosacea to hypertension, dyslipidemia, inflammatory bowel disease, and anxiety and depression. To assess dermatologists' awareness of and screening practices for rosacea comorbidities, we developed a survey that was distributed to attendings and residents across four academic dermatology departments in Massachusetts. A total of 73 dermatologists with varying experience participated in the study. Findings demonstrated significant knowledge and practice gaps among academic dermatologists in managing systemic comorbidities in rosacea. In addition, dermatologists' awareness of rosacea comorbidities was negatively correlated with number of years out of residency training, highlighting the need to address this knowledge gap through increased continuing medical education. Importantly, we observed a low screening frequency despite a high awareness of the association between rosacea and ocular comorbidities, suggesting that additional financial, institutional, or practice barriers likely contribute to the low screening rate.
Identifiants
pubmed: 34510277
doi: 10.1007/s00403-021-02279-y
pii: 10.1007/s00403-021-02279-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
995-997Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J et al (2018) Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 78(1):148–155
doi: 10.1016/j.jaad.2017.08.037
Gether L, Overgaard LK, Egeberg A, Thyssen JP (2018) Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol 179(2):282–289
pubmed: 29478264
Chen Q, Shi X, Tang Y, Wang B, Xie HF, Shi W et al (2020) Association between rosacea and cardiometabolic disease: a systematic review and meta-analysis. J Am Acad Dermatol 83(5):1331–1340
doi: 10.1016/j.jaad.2020.04.113
Han J, Liu T, Zhang M, Wang A (2019) The relationship between inflammatory bowel disease and rosacea over the lifespan: a meta-analysis. Clin Res Hepatol Gastroenterol 43(4):497–502
doi: 10.1016/j.clinre.2018.09.009
Haber R, El Gemayel M (2018) Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol 78(4):786–92.e8
doi: 10.1016/j.jaad.2017.09.016
Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B et al (2004) Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 69(3):548–556
pubmed: 14971837
Manalo IF, Gilbert KE, Wu JJ (2015) Survey of trends and gaps in dermatologists’ cardiovascular screening practices in psoriasis patients: areas still in need of improvement. J Am Acad Dermatol 73(5):872–4.e4
doi: 10.1016/j.jaad.2015.07.029
Rainer BM, Fischer AH, da Luz Felipe Silva D, Kang S, Chien AL (2015) Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case–control study. J Am Acad Dermatol 73(4):604–608
doi: 10.1016/j.jaad.2015.07.009